Senior International Medical Director for Cell Therapy

x

Are you ready to leverage your expertise in cell therapy and Type 1 Diabetes (T1D) to lead groundbreaking projects that redefine patient care at Novo Nordisk? Would you like to join a global pharmaceutical leader and drive innovation as a Senior International Medical Director?
If you're passionate about advancing medical science and shaping the future of cell therapy, this is your opportunity to make a lasting impact, apply now for a life-changing career!

The position
As a Senior International Medical Director, reporting to Head of Development in CTRD, you will be working with cross-functional teams, incl. clinical operations, non-clinical research, Medical Writing, Program Management, Regulatory Affairs, CMC, Device engineering, commercial and other functions and will be a key representative interacting with internal and external stakeholders, including KOLs and PIs.  

Your primary responsibilities will include:
•    Be medically responsible for assigned projects in the T1D space in Cell Therapy R&D portfolio.
•    Act as consultant/expert on medically related issues within Cell Therapy R&D.
•    Design and outline Cell Therapy clinical development strategies, plans and trials including timely implementation.
•    Provide strategic leadership in the T1D therapeutic area Cell Therapy R&D TRU.
•    Represent cell therapy and T1D therapeutic area across NN.
•    Lead or be an actively contributing member of Global Project Teams and/or Clinical Development Team(s).

The role is based in Maaloev, Denmark and involves working with a global team across several time zones (some of which are 9-hours apart). Travel requirement is estimated to be 10%.

Qualifications
To thrive and succeed in the role, we expect you to have:
•    University degree in Life Sciences: MD, PhD, or MD/PhD. 
•    7 years+ of relevant experience within clinical research or pharmaceutical drug development.
•    Experience in Endocrinology or Diabetes therapeutic area; advanced therapeutic medicinal therapies (ATMP) experience incl. cell therapy would be an asset.
•    Comprehensive understanding of global drug development and the R&D value chain. 
•    Experience in interaction with global regulatory authorities.

On a personal level, you possess strong networking skills and are adept at engaging with KOLs and NN Development leaders. You bring experience in navigating large, international matrix organizations, which complements your leadership capabilities, project management expertise, and effective communication and presentation skills. Additionally, you demonstrate a strong collaborative mindset, essential for fostering teamwork and achieving shared objectives. Your proficiency in both written and spoken English is at an advanced level, further enhancing your ability to communicate across diverse, global teams.

About the department
In Cell Therapy R&D, our mission is to improve the lives of patients suffering from serious chronic diseases through innovative stem cell-based therapies. We want to be an industry leader in this rapidly developing area, which has the potential to address unmet medical needs and even cure serious chronic diseases. As a dedicated Transformational Research Unit (TRU) since late 2018, we have a high level of independence, agility and flexibility. This means we can combine the speed and agility of a small biotech with the capabilities of a major pharma company. We cover the full pharmaceutical value chain, from research to commercial, including a GMP manufacturing site in Fremont, working in close collaboration with leading international scientists and colleagues across Novo Nordisk. Novo Nordisk has been active in stem cell research for over 20 years in type 1 diabetes. Our portfolio has since expanded to many disease areas and indications, all working towards maturing and expanding our platform and capabilities.

The Cell Therapy Development area is part of Cell Therapy R&D and encompasses an organization of approximately 22 professionals spread across several locations and time zones. Located at our Maaloev site in Denmark, the team collaborates closely with the larger Novo Nordisk Development organization, including the newly formed US-based “East Coast Hub” and our commercial partners in Rare Disease. The department is known for its collaborative and innovative approach to drug development, and we are committed to making a difference in the lives of patients.

Working at Novo Nordisk
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.

Contact
For further information, please contact Marzena Herok at ozhk@novonordisk.com

Deadline
1 December 2024

You do not need to attach a cover letter to your application, but please include a few sentences about why you are applying in your CV. 
To ensure an efficient and fair recruitment process, please refrain from adding a photo in your CV. 
Applications will be evaluated continuously when received, and candidates may be called for interview before the deadline.

We commit to an inclusive recruitment process and equality of opportunity for all our job applicants. 

At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.